Filing Details

Accession Number:
0001345568-12-000009
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-20 17:58:03
Reporting Period:
2012-03-14
Filing Date:
2012-03-20
Accepted Time:
2012-03-20 16:58:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1053369 Elite Pharmaceuticals Inc ELTP Pharmaceutical Preparations (2834) 223542636
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1442002 Epic Pharma Llc 227-15 North Conduit Ave
Laurelton NY 11413-3134
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-14 7,621,951 $0.00 63,443,669 No 4 C Indirect see footnote
Common Stock Disposition 2012-03-16 85,000 $0.10 63,358,669 No 4 S Indirect see footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect see footnote
No 4 S Indirect see footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series E Convertible Preferred Stock Disposition 2012-03-14 188 $1,000.00 7,621,951 $0.02
Common Stock Series E Convertible Preferred Stock Acquisiton 2012-03-15 125 $1,000.00 5,081,301 $0.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,625 2012-03-14 No 4 C Indirect
1,750 2012-03-15 No 4 P Indirect
Footnotes
  1. Conversion of Series E Preferred Stock of issuer at the rate of approximately 40,650.41 shares of common for each share of such preferred stock.
  2. The reporting person, Epic Pharma, LLC ("EP"), is an equity owner of Epic Investments, LLC ("EI"), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer. EP and EI are both owned, wholly or in part, and are operated by Ram Potti, Ashok G. Nigalaye and Jeenarine Narine, each of whom is a director of the issuer. The interest of EP in the securities of the issuer owned by EI is limited, and EP disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.
  3. N/A